Stem cells in disease
Stem cell dysfunction underlies a range of diseases and health challenges that face the global population today. From neurodegenerative and cardiovascular diseases to cancer and ageing, stem cell dysregulation is implicated across the disease spectrum.
Our researchers are investigating the reasons behind the dysfunction, focusing particularly on malignancy, cancer pathophysiology, and regenerative failure, to better understand how diseases may be treated in future.
Our group leaders work across different disease areas, listed below. Some are currently involved in clinical trials, which you can find here.
More information on each researcher's specific area can be found on their group pages.
| Professor Roger Barker | Key diseases: Parkinson's disease & Huntington's disease |
| Prof Bertie Göttgens | Key disease: Leukaemia |
| Dr Daniel Hodson | Key disease: Lymphoma |
| Prof Brian Huntly | Key diseases: Leukaemia and Lymphoma |
| Dr Ragnhildur Thóra Káradóttir | Key disease: Multiple sclerosis |
| Dr Elisa Laurenti | Key disease: Leukaemia |
| Prof Andrew McCaskie | Key disease: Arthritis |
| Dr Simón Méndez-Ferrer | Key disease: Leukaemia |
| Dr Sanjay Sinha | Key disease: Cardiovascular disease |
| Dr Kostas Tzelepis | Key disease: Leukaemia |
| Professor George Vassiliou | Key disease: Leukaemia |